CN107974432B - 高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 - Google Patents
高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 Download PDFInfo
- Publication number
- CN107974432B CN107974432B CN201710687334.4A CN201710687334A CN107974432B CN 107974432 B CN107974432 B CN 107974432B CN 201710687334 A CN201710687334 A CN 201710687334A CN 107974432 B CN107974432 B CN 107974432B
- Authority
- CN
- China
- Prior art keywords
- culture
- fermentation
- protein
- medium
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101710125507 Integrase/recombinase Proteins 0.000 title claims abstract description 26
- 210000004978 chinese hamster ovary cell Anatomy 0.000 title claims abstract description 19
- 238000012136 culture method Methods 0.000 title claims abstract description 19
- 206010008631 Cholera Diseases 0.000 title claims abstract description 17
- 230000003248 secreting effect Effects 0.000 title claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 73
- 230000004151 fermentation Effects 0.000 claims abstract description 73
- 210000004027 cell Anatomy 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 19
- 230000003321 amplification Effects 0.000 claims abstract description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 7
- 239000001301 oxygen Substances 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 7
- 241001212789 Dynamis Species 0.000 claims description 13
- 239000004017 serum-free culture medium Substances 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 239000012679 serum free medium Substances 0.000 claims description 5
- 238000012807 shake-flask culturing Methods 0.000 claims description 5
- 108010008529 bovine viral diarrhea virus gp53 Proteins 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 2
- 238000013341 scale-up Methods 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 abstract description 19
- 238000003756 stirring Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 239000002609 medium Substances 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 13
- 241000282898 Sus scrofa Species 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 241000710777 Classical swine fever virus Species 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007640 basal medium Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000001726 Classical Swine Fever Diseases 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108010076039 Polyproteins Proteins 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000013595 supernatant sample Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- -1 CD efficiency Feed C Substances 0.000 description 1
- 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 description 1
- SXTAYKAGBXMACB-DPVSGNNYSA-N L-methionine sulfoximine Chemical compound CS(=N)(=O)CC[C@H](N)C(O)=O SXTAYKAGBXMACB-DPVSGNNYSA-N 0.000 description 1
- QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 101710144128 Non-structural protein 2 Proteins 0.000 description 1
- 101710144111 Non-structural protein 3 Proteins 0.000 description 1
- 101800001020 Non-structural protein 4A Proteins 0.000 description 1
- 101800001019 Non-structural protein 4B Proteins 0.000 description 1
- 101800001014 Non-structural protein 5A Proteins 0.000 description 1
- 101710199667 Nuclear export protein Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710687334.4A CN107974432B (zh) | 2017-08-11 | 2017-08-11 | 高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710687334.4A CN107974432B (zh) | 2017-08-11 | 2017-08-11 | 高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107974432A CN107974432A (zh) | 2018-05-01 |
CN107974432B true CN107974432B (zh) | 2021-04-23 |
Family
ID=62012306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710687334.4A Active CN107974432B (zh) | 2017-08-11 | 2017-08-11 | 高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107974432B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109468268B (zh) * | 2018-11-26 | 2020-08-14 | 广州伯尼兹生物科技有限公司 | 一种培养hek-293t细胞株高效分泌表达猪瘟e2蛋白的方法及应用 |
CN117305393B (zh) * | 2023-11-28 | 2024-02-27 | 金宇保灵生物药品有限公司 | 提高csfv-e2蛋白表达量的培养基的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102382794A (zh) * | 2010-09-01 | 2012-03-21 | 山东新时代药业有限公司 | 一种哺乳动物细胞的灌流培养方法 |
CN102443565A (zh) * | 2010-09-30 | 2012-05-09 | 成都康弘生物科技有限公司 | 一种适于培养cho细胞的培养基及其培养工艺 |
CN103320390A (zh) * | 2013-06-17 | 2013-09-25 | 齐鲁制药有限公司 | 一种大规模哺乳动物工程细胞培养方法 |
-
2017
- 2017-08-11 CN CN201710687334.4A patent/CN107974432B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102382794A (zh) * | 2010-09-01 | 2012-03-21 | 山东新时代药业有限公司 | 一种哺乳动物细胞的灌流培养方法 |
CN102443565A (zh) * | 2010-09-30 | 2012-05-09 | 成都康弘生物科技有限公司 | 一种适于培养cho细胞的培养基及其培养工艺 |
CN103320390A (zh) * | 2013-06-17 | 2013-09-25 | 齐鲁制药有限公司 | 一种大规模哺乳动物工程细胞培养方法 |
Non-Patent Citations (2)
Title |
---|
Production of Classical Swine fever Virus Envelope Glycoprotein E2 as Recombinant Polyhedra in Baculovirus-infected Silkworm Larvase;Kwang Sik LEE,et al;《Mol Biotechnol》;20120331;第50卷;211-220 * |
稳定表达猪圆环病毒2型Cap蛋白的CHO-K1细胞系的建立及免疫原性分析;武乐伟,吴素芳 等;《畜牧兽医学报》;20191231;第50卷(第5期);1056-1063 * |
Also Published As
Publication number | Publication date |
---|---|
CN107974432A (zh) | 2018-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100335619C (zh) | 大规模生产病毒抗原的方法 | |
CN110237246B (zh) | 一种全悬浮细胞培养禽流感(h9)灭活疫苗的方法 | |
CN107460156B (zh) | 无血清全悬浮mdck细胞株及其在生产流感病毒中的应用 | |
RU2007119719A (ru) | Не содержащая животных белков среда для культивирования клеток | |
CN114317405B (zh) | 无血清全悬浮培养型f81细胞系及其构建方法与应用 | |
CN107299078B (zh) | 一株适应全悬浮培养的猫肾细胞系f-81 s及其应用 | |
CN107974432B (zh) | 高效分泌表达猪瘟e2蛋白的cho细胞株的培养方法及其应用 | |
CN106148296A (zh) | 一种重组谷氨酰胺转氨酶的生产方法 | |
CN107841482B (zh) | Mdck细胞无血清悬浮培养技术生产h9亚型流感疫苗 | |
CN110484465B (zh) | 一种vbnc细菌的复苏培养基及其制备方法与应用 | |
WO2022095987A1 (zh) | 一种通过灌流培养工艺制备腺病毒载体疫苗的方法 | |
CN114736871A (zh) | 一种腺病毒包装wayne293 lvpro动物细胞培养方法 | |
CN103937748B (zh) | 可稳定表达人tmprss2蛋白的单细胞自悬浮生长mdck细胞株及其构建方法与应用 | |
CN102406927A (zh) | 一种人二倍体细胞乙型脑炎灭活疫苗的生产方法 | |
CN104673814A (zh) | 一种来自于阴沟肠杆菌的l-苏氨酸醛缩酶及其应用 | |
CN107858322B (zh) | 一种海马原代细胞培养体系的建立方法 | |
CN114736846A (zh) | 一种提高腺病毒生产的wayne293 lvpro细胞培养基添加物及制作方法 | |
CN112501091B (zh) | 哈维氏弧菌cheA基因沉默细胞株及其应用 | |
CN106676058A (zh) | 一种bhk21悬浮细胞高密度流加培养方法及其在口蹄疫病毒增殖中的应用 | |
CN103014166A (zh) | 一种植物乳杆菌st-ⅲ耐盐基因的筛选方法 | |
CN105950571A (zh) | 一种基于鲤鱼上皮瘤细胞epc的鳜鱼传染性脾肾坏死病毒isknv的增殖方法 | |
CN104805053A (zh) | 珍珠龙胆石斑鱼吻端组织细胞系及其构建方法、应用 | |
CN105543123A (zh) | 一株生产抗氧化肽的苏云金芽孢杆菌及其筛选方法 | |
CN104745634A (zh) | 提高利用昆虫杆状病毒表达系统表达外源蛋白效率的方法 | |
CN111979200A (zh) | 一种鸭坦布苏病毒的无血清全悬浮培养方法及其在疫苗中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 312366 No. 1, Baichuan Road, Binhai New Area, Shaoxing City, Zhejiang Province Patentee after: NOVO BIOTECH Corp. Address before: 312000 5th floor, building 2, science and innovation center, 398 mahuan Road, Binhai New Town, Shaoxing City, Zhejiang Province Patentee before: NOVO BIOTECH Corp. |
|
CP02 | Change in the address of a patent holder | ||
CP03 | Change of name, title or address |
Address after: 312366 No. 1, Baichuan Road, Binhai New Area, Shaoxing City, Zhejiang Province Patentee after: Zhejiang Hailong Biotechnology Co.,Ltd. Country or region after: China Address before: 312366 No. 1, Baichuan Road, Binhai New Area, Shaoxing City, Zhejiang Province Patentee before: NOVO BIOTECH Corp. Country or region before: China |